Literature DB >> 25624974

An overview of neurovascular disease management.

Gavin Britz1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25624974      PMCID： PMC4300058          DOI： 10.14797/mdcj-10-4-212

Source DB:  PubMed          Journal:  Methodist Debakey Cardiovasc J        ISSN： 1947-6108


× No keyword cloud information.
  5 in total

1.  Panacea or problem: flow diverters in the treatment of symptomatic large or giant fusiform vertebrobasilar aneurysms.

Authors:  Adnan H Siddiqui; Adib A Abla; Peter Kan; Travis M Dumont; Shady Jahshan; Gavin W Britz; L Nelson Hopkins; Elad I Levy
Journal:  J Neurosurg       Date:  2012-03-09       Impact factor: 5.115

2.  Transient adenosine-induced asystole during the surgical treatment of anterior circulation cerebral aneurysms: technical note.

Authors:  Ciaran J Powers; David R Wright; David L McDonagh; Cecil O Borel; Ali R Zomorodi; Gavin W Britz
Journal:  Neurosurgery       Date:  2010-12       Impact factor: 4.654

3.  Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial.

Authors:  Colin P Derdeyn; Marc I Chimowitz; Michael J Lynn; David Fiorella; Tanya N Turan; L Scott Janis; Jean Montgomery; Azhar Nizam; Bethany F Lane; Helmi L Lutsep; Stanley L Barnwell; Michael F Waters; Brian L Hoh; J Maurice Hourihane; Elad I Levy; Andrei V Alexandrov; Mark R Harrigan; David Chiu; Richard P Klucznik; Joni M Clark; Cameron G McDougall; Mark D Johnson; G Lee Pride; John R Lynch; Osama O Zaidat; Zoran Rumboldt; Harry J Cloft
Journal:  Lancet       Date:  2013-10-26       Impact factor: 79.321

4.  International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion.

Authors:  Andrew J Molyneux; Richard S C Kerr; Ly-Mee Yu; Mike Clarke; Mary Sneade; Julia A Yarnold; Peter Sandercock
Journal:  Lancet       Date:  2005 Sep 3-9       Impact factor: 79.321

5.  Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial.

Authors:  J P Mohr; Michael K Parides; Christian Stapf; Ellen Moquete; Claudia S Moy; Jessica R Overbey; Rustam Al-Shahi Salman; Eric Vicaut; William L Young; Emmanuel Houdart; Charlotte Cordonnier; Marco A Stefani; Andreas Hartmann; Rüdiger von Kummer; Alessandra Biondi; Joachim Berkefeld; Catharina J M Klijn; Kirsty Harkness; Richard Libman; Xavier Barreau; Alan J Moskowitz
Journal:  Lancet       Date:  2013-11-20       Impact factor: 79.321
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.